The global cold chain packaging market size was valued at USD 28.14 billion in 2024. It is projected to grow from USD 30.88 billion in 2025 and to USD 64.49 billion by 2032, exhibiting a CAGR of 11.09% during the forecast period. Cold chain packaging encompasses specialized solutions that ensure temperature-sensitive products remain within the required temperature range throughout the supply chain. This is crucial for maintaining the quality and effectiveness of perishable items such as vaccines, fresh produce, and biologics.

Sancell and Cold Chain Technologies are among the top manufacturers in this segment, commanding the largest share of the global cold chain packaging market.

Fortune Business Insights™ presents this information in its report titled “Cold Chain Packaging Market, 2025-2032.

Get a Free Sample PDF Brochure:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cold-chain-packaging-market-102829

Segmentation Analysis:

How is the cold chain packaging market segmented by product type?

The market is segmented into EPS containers, PUR containers, pallet shippers, vacuum insulated panels, and others. Among these, the pallet shippers segment is expected to dominate due to its larger capacity, universal temperature protection, and reusable nature, making it highly effective for shipping.

Which application segment holds the largest share in the cold chain packaging market?

The market is categorized by application into pharmaceuticals, food, and industrial sectors. The food segment is projected to hold the largest share owing to the growing adoption of vaccines, medicines, and medical drugs. Additionally, strong investments from the pharmaceutical packaging industry are expected to further boost market growth.

Driving Factors:

What are the key factors driving the growth of the cold chain packaging market?

The market is primarily driven by robust demand from the pharmaceutical industry. Cold chain packaging is essential for shipping products requiring controlled temperatures, such as injections, vaccines, and medicines. According to IQVIA’s Pharmaceutical Commerce Analysis (2018), cold chain investments account for nearly 18% of total pharmaceutical product investments. Rising international trade of pharmaceutical products is also expected to increase adoption.

What challenges could restrain the cold chain packaging market?

Market growth may be hindered by complex regulations and high costs associated with the packaging solutions.

Regional Insights:

How is the cold chain packaging market performing across different regions?